FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RAVULIZUMAB
异名/同义词RAVULIZUMAB-CWVZ
RAVULIZUMAB-CWVZ [PURPLE BOOK CDER]
RAVULIZUMAB CWVZ [WHO-DD]
ALXN-1210
ALXN1210
IMMUNOGLOBULIN G2/G4, ANTI-(HUMAN COMPLEMENT C5) (HUMAN-MUS MUSCULUS ALXN1210 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS ALXN1210 .KAPPA.-CHAIN, DIMER
RAVULIZUMAB
RAVULIZUMAB [JAN]
RAVULIZUMAB [MI]
RAVULIZUMAB [USAN]
RAVULIZUMAB [WHO-DD]
RAVULIZUMAB [INN]
ULTOMIRIS
CAS登记号1803171-55-2
物质唯一标识(Unique Ingredient Identifier)C3VX249T6L
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System